# Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

> **NCT02979054** · NA · COMPLETED · sponsor: **Laboratoires Thea** · enrollment: 157 (actual)

## Conditions studied

- Keratoconus

## Interventions

- **DEVICE:** T4020
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02979054
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02979054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02979054, "Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02979054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*